Belarusian cardiology has made significant progress, but doctors and scientists need to continue working closely together to ...
HUAWEI’s newest wearables, the HUAWEI WATCH GT 7 Series and HUAWEI WATCH D3, are now officially available in the Philippines, ...
Strong financials, accelerated growth trends, and a guidance update reflect on a favorable outlook for Medtronic plc ...
In a state first, participating Victorian pharmacists can now dispense a one-month resupply of menopausal hormone therapy ...
Data from Bayer’s cardiovascular portfolio in heart failure and cardiac amyloidosis will be presented, including ...
Novel RNAi therapeutic targeting INHBE aims to address obesity and associated cardiometabolic disorders Suzhou Ribo Life ...
Basel, 9 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab ...
New model enables researchers to explore how Hutchinson-Gilford Progeria Syndrome affects three layers of cells in blood ...
Increased consumption of potassium-rich foods that are part of the Dietary Approaches to Stop Hypertension (DASH) diet did ...
A $25 million gift from the Smilow Foundation, led by William Smilow, will establish the Smilow Center for Precision ...
Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at ...
The supplemental New Drug Application (sNDA) was supported by results from the Phase III FIND-CKD trial investigating KERENDIA® (finerenone) in adults with chronic kidney disease (CKD) without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results